WHO ICTRP trial
Explorative trial to investigate catumaxomab (antibody) for treatment of…
EUCTR2010-024111-13-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-024111-13-DE |
|---|---|
| Public title | Explorative trial to investigate catumaxomab (antibody) for treatment of peritoneal carcinomatosis in patients with gastric cancer prior to surgery (resection) |
| Scientific title | Explorative trial to investigate catumaxomab (anti-EpCAM x anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric adenocarcinomas prior to gastrectomy - Catumaxomab for peritoneal carcinomatosis in gastric cancer |
| Primary sponsor | AIO-Studien-gGmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | Gastric adenocarcinoma and carcinoma of the esophago-gastric junction (type II and type III according to Siewert’s classification) prior to gastrectomy, with peritoneal carcinomatosis. MedDRA version: 15.1 Level: PT Classification code… |
| Interventions | Trade Name: Removab Pharmaceutical Form: Concentrate for solution for infusion |
| Registration date | Jan 2, 2011 |
| Secondary IDs | AIO-STO-0110 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: